Get started
Author

Jack Ishak

Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
2013 · Karin Jordan, Irina Proskorovsky, et al. · Supportive Care in Cancer · 137
PDF
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
2014 · Irina Proskorovsky, Philip Lewis, et al. · Health and Quality of Life Outcomes · 77
PDF
Cost-Effectiveness of Eplerenone Compared With Placebo in Patients With Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure
2005 · William S. Weintraub, Zefeng Zhang, et al. · Circulation · 77
Discrete Event Simulation for Health Technology Assessment
2015 · J. Jaime Caro, Jörgen Möller, et al. · Chapman & Hall/CRC eBooks · 51
Lifetime economic burden of prostate cancer
2011 · Michael E Stokes, Jack Ishak, et al. · BMC Health Services Research · 46
PDF
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis
2017 · Robert Leipold, Frederick Raal, et al. · European Journal of Preventive Cardiology · 38
Declining Rates of Adverse Events and Dose Modifications with Lenalidomide in Combination with Dexamethasone
2008 · Jack Ishak, Meletios A Dimopoulos, et al. · Blood · 20
Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis
2003 · Jaime Caro, Denis Getsios, et al. · BMC Geriatrics · 18
PDF
Sunitinib (SU) in patients with advanced, progressive pancreatic neuroendocrine tumors (pNET): Final overall survival (OS) results from a phase III randomized study including adjustment for crossover.
2016 · Eric Raymond, Patricia Niccoli, et al. · Journal of Clinical Oncology · 9
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease
2024 · Matthias Boentert, Kenneth I. Berger, et al. · Orphanet Journal of Rare Diseases · 8
PDF
Modelling survival in hepatocellular carcinoma
2012 · Noemi Muszbek, Noemi Kreif, et al. · Current Medical Research and Opinion · 8
Economic Evaluation of Lenalidomide Combined with Dexamethasone for the Treatment of Multiple Myeloma in the UK
2008 · Baris Deniz, Gareth Morgan, et al. · Blood · 7
Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
2017 · Jack Ishak, Michael Rael, et al. · Journal of Clinical Hypertension · 6
PDF
Deriving health utility values from a randomized, double-blind, placebo-controlled trial of siltuximab in subjects with multicentric Castleman’s disease
2016 · Margaret Vernon, Don Robinson, et al. · Current Medical Research and Opinion · 6
Projecting survival with cure mixture models: when are the data mature enough for reliable analysis?
2018 · J Ishak, CF Villalobos, et al. · Value in Health · 3
PDF
Indirect Comparisons to Assess the Relative Efficacy of Carfilzomib + Lenalidomide + Dexamethasone Versus Panobinostat + Bortezomib + Dexamethasone and Bortezomib + Dexamethasone: A Matching Adjusted Indirect Comparison
2015 · Michael Rael, Agnes Benedict, et al. · Blood · 3
THU0207 Comparative Analysis of the Effectiveness of anti-TNF Therapies in Non-Radiographic Axial Spondyloarthritis Using Novel Statistical Techniques
2015 · A. Benedict, J. Ishak, et al. · Annals of the Rheumatic Diseases · 2
Reframing Population-Adjusted Indirect Comparisons as a Transportability Problem: An Estimand-Based Perspective and Implications for Health Technology Assessment
2026 · Chandler, Conor, Ishak, Jack · arXiv (Cornell University) · 1
PDF
Indirect Comparison to Assess the Relative Efficacy of Carfilzomib + Lenalidomide + Dexamethasone Versus Bortezomib + Thalidomide + Dexamethasone: A Matching Adjusted Indirect Comparison
2015 · Michael Rael, Agnes Benedict, et al. · Blood · 1
Cost effectiveness of treatments for relapsed/refractory multiple myeloma: response to a methodology
2011 · Jack Ishak, Filipe Rodrigues · European Journal Of Haematology · 1
Overall Survival (OS) Analysis of Sunitinib (SU) after Adjustment for Crossover (CO) in Patients with Pancreatic Neuroendocrine Tumors (NET)
2011 · Jack Ishak, Juan W. Valle, et al. · Neuroendocrinology · 1
P3‐224: Updated cost‐effectiveness projections for donepezil in the treatment of patients with mild‐to‐moderately severe Alzheimer's disease in the UK
2009 · Grant Maclaine, Denis Getsios, et al. · Alzheimer s & Dementia · 1
Anchors Away: Navigating Single-Arm Indirect Comparisons with Multilevel Unanchored Meta-Regression (ML-UMR-SA)
2026 · Chandler, Conor, Ishak, K. Jack · arXiv (Cornell University)
PDF
Msr131 Surviving Unanchored Indirect Comparisons: an Extension of Multilevel Unanchored Meta-regression (ml-umr) for Survival Analyses
2026 · Conor Chandler, Jack Ishak · Value in Health
Avalglucosidase alfa improves motor and respiratory function in late-onset Pompe disease: A COMET win-ratio analysis
2023 · Jordi Diaz-Manera, Mazen M. Dimachkie, et al. · Molecular Genetics and Metabolism
Works count: 34
Citation count: 521
H-index: 9
I10-index: 8
Year
Topic
Type